Drug-induced Liver Injury - Gibson

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:45 AM on 12/9/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

27 Terms

1
New cards
  • adverse toxic drug reaction resulting in liver injury

  • Liver is exposed to all substances circulating in the body - prone to injury

  • Over 1,100 meds that are considerate for heaptotoxcity

  • causes 11-13% of all acute liver failures in the US

    • 2000 fulminant cases annually

  • Hepatotoxicity is #1 cause for post-market drug withdrawal

DILI definition

2
New cards

Female

Adults

Alcohol

Malnutrition

Risk factors for DILI

3
New cards

Need

  • Elevated Liver enzymes + Drug culprit

Drug culprit

  • causality established/strongly suspected using a validated tool (RUCAM) or DILI scoring

How to diagnose DILI

4
New cards
  • used to estimate hepatotoxic potential of drugs in trials

  • Sensitive and specific predictor of a drugs potential to cause severe liver injury

  • Patients have >10 % risk of mortality from DILI if TWO OR MORE of following

    • AST/ALT > 3x ULN

    • Totally bili > 2x ULN WITHOUT cholestasis

    • No alternative causes of LFT elevations

    • Some sources add jaundice

What is HY’s Law?

5
New cards

Direct toxicity

  • Acetaminophen, amiodarone, anabolic steroids, valproic acid, statins, HAART

DILI categorization (Intrinsic)

6
New cards

R <2 = Cholestatic

  • Amox/Clav, trimethoprim, azathioprine

R (2-5) = Mixed

  • Fluoroquinolones, macrolides, phenytoin, carbamazepine

R > 5 = Hepatocellular

  • Isoniazid, nitrofurantoin, lamotrigine, PPI’s, TNF-Alpha inhibitors

DILI categorization (Idiosyncratic)

7
New cards

Steatohepatitis

  • AMio, tamoxifen, methotrexate

Neoplastic

  • Anabolic steroids

Vascular

  • Azathioprine

DILI categorization (Other)

8
New cards
  • Dose dependent injury

  • Onset of hours to days

  • Predictable

  • Lipophilic drug characteristics

  • Reactive metabolites - oxidative stress (mechanism)

Intrinsic DILI categorization/symptoms

9
New cards
  • NOT Dose dependent injury

  • Onset of weeks to months

  • Unpredictable

  • Variable mechanism (may be allergic or non-allergy)

  • Based on injury pattern or score

Idiosyncratic DILI categorization/symptoms

10
New cards
  • Damages liver cells

  • Variable reversibility

  • Significant LFT elevations

    • ALT >800 U/L or >20 ULN + Bilirubin elevated

  • R > 5

  • General sx of liver toxicity

  • impacts PT/INR

  • Worse outcomes

Hepatocellular DILI points

11
New cards
  • Damages bile flow

  • Usually reversible

  • AlkPhos > 3x ULN + Bilirubin elevated

  • R <2

  • Pruritis, jaundice, eosinophilia, etc

  • Impacts PT/INR

  • Less Morbid!!!

Cholestatic DILI points

12
New cards

R = (ALT / ALT ULN) / (ALP / ALP ULN)

  • Hepatocellular DILI = R >5

  • Mixed DILI - (R = 2-5)

  • Cholestatic DILI = R <2

Hepatocellular vs Cholestatic DILI - R value interpretations

13
New cards

Discontinue Drug!!!

  • Decisions guided by patient specific factors

  • Spontaneous recovery usually occurs after drug D/C (and confirms it was drug caused)

Main treatment for DILI

14
New cards

Supportive care

  • Hospitalize patients with signs of liver failure

    • Jaundice, encephalopathy, coagulopathy

  • Serial measurement of LFTS for all patients

  • Consider Vit K for coagulopathy

  • Consider Cholestyramine or colestipol for pruritus

Additional DILI treatment

15
New cards

Cholestyramine

If a patient experiences DILI (hepatotoxicity) with Leflunamide OR Terbinafine, what would you give them as therapy?

16
New cards

Carnitine

If a patient experiences DILI (hepatotoxicity) with Valproate, what would you give them as therapy?

17
New cards

Leucovorin

If a patient experiences DILI (hepatotoxicity) with Methotrexate, what would you give them as therapy?

18
New cards

N-Acetylcysteine (NAC)

If a patient experiences DILI (hepatotoxicity) with Acetaminophen , what would you give them as therapy?

19
New cards
  • CANNOT be resumed in FULMINANT disease

  • Med rechallenge should only be considered IF:

    • Drug-induced mechanism is uncertain

    • Great need for the medication

    • Lack of of other treatment options

    • ALl sx have resolved

  • Resume at HALF DOSE

  • Monitor LFTS quickly + often

Points about possible rechallenge of drugs after a DILI

20
New cards

The Glucoronidation and Glutathione conjugation pathways that form the stable metabolites for excretion become OVERSATURATED

  • Cause the covalent binding and oxidative stress that kills hepatocytes

How does Acetaminophen Overdose happen? (pathophys)

21
New cards
  • Most effective when given promptly (within 8-10 hours) after acute ingestion

  • Serves as Glutathione substitute - enhances the non-toxic sulfating conjugation of Tylenol

Easy way: Supplements stable metabolites!!!

How does NAC work and treat Acetaminophen overdose?

22
New cards

Chronic Toxicity of Tylenol

  • Only administer if acetaminophen levels > 20 mcg/mL AND LFT elevations

NAC is ineffective for _____ and should only administer when?

23
New cards
  • Always administer for ingestions > 30 grams

  • Check Tylenol blood levels within 4-24 hours of ingestion for other patients

    • Do not allow lab delays to interfere with treatment

    • Compare levels to Rumack Matthew nomogram

Decision to administer points for NAC

24
New cards
  1. take Tylenol level

  2. plot on Axis

  3. If ABOVE THE SOLID DIAGONAL LINE - Treat with NAC!!!!

Rumack-Matthew Nomogram points

25
New cards

Dosing goal: deliver > 300 mg/kg IV or PO in first 20-24 hours

“Three Bag regimen”

  1. Load: 150 mg/kg (max 15g) IV over 1 hour

  2. Second Dose: 50 mg/kg (max 5g) over 4 hours

  3. Third Dose: 100 mg/kg (max 10g) over 15 hours

  4. Evaluate for stopping criteria

NAC dosing goal + dosing

26
New cards
  1. APAP level <10 mcg/mL

  2. INR < 2

  3. LFTS normal or reduced by 25%-50%

  4. Clinical stability

What are the stopping criteria for NAC? (Must have all of them to stop NAC)

27
New cards
  • Edema

  • Facial flush

  • Skin rash

  • Pruritus

  • Urticaria (hives)

  • Hypersenstivity

  • Vomiting

NAC adverse reactions

Explore top flashcards

Set 1 (Fall Comp 1)
Updated 905d ago
flashcards Flashcards (25)
B1.1 Lipids
Updated 868d ago
flashcards Flashcards (32)
Ekologija
Updated 445d ago
flashcards Flashcards (104)
MGMT 105 Final
Updated 1173d ago
flashcards Flashcards (228)
Microbio Exam 5
Updated 803d ago
flashcards Flashcards (321)
Genetics
Updated 1045d ago
flashcards Flashcards (23)
Set 1 (Fall Comp 1)
Updated 905d ago
flashcards Flashcards (25)
B1.1 Lipids
Updated 868d ago
flashcards Flashcards (32)
Ekologija
Updated 445d ago
flashcards Flashcards (104)
MGMT 105 Final
Updated 1173d ago
flashcards Flashcards (228)
Microbio Exam 5
Updated 803d ago
flashcards Flashcards (321)
Genetics
Updated 1045d ago
flashcards Flashcards (23)